Twist Bioscience Corporation

NASDAQ:TWST

Medical - Diagnostics & Research

Healthcare
$116.35 +2.59%

+$2.15 today

Market cap
$7.66B
Beta
2.21
P/E (TTM)
-64.5
EPS (TTM)
-$1.32
52W Low $23.30High $88.46

Volume 2.23M

Average 1.53M

TWST Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Twist Bioscience CorporationNASDAQ: TWST

Operating Margin · Q4 FY2026 · quarter ended Sep 2026

Operating margin widens to -25.0%

Operating margin was -25.0% in Q4 FY2026, up 5.3 pp from a year earlier. On a trailing-twelve-month basis it was -30.4%, up 5.8 pp year over year. Over 3 fiscal years it widened by 58.2 pp.

Context

  • Operating margin widened in 3 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

What to watch

Whether operating margin reaches the consensus estimate from 8 analysts of -15.3% for the fiscal year ending Sep 2027, up from -30.4% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
-25.0%+5.7 pp QoQ
Last fiscal yearSep 2026
-30.4%+5.8 pp YoY
LTMSep 2026
-30.4%+5.8 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.3 pp+14.4 pp+9.1 pp
1 year+5.8 pp+15.0 pp+9.2 pp
3 years+58.2 pp+29.8 pp-28.4 pp
5 years+44.9 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2026
-30.4%
Year-over-year change
+5.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How TWST compares with its peers on the latest reported figures

  • TWST's LTM Sep 2026 operating margin of -30.4% is the lowest of the 2 companies compared; the peer median is 8.3%.
  • Its year-over-year change of +5.8 pp is the lowest of 2, against a peer median of +11.9 pp.
  • Over three fiscal years its change of +58.2 pp compares with a peer median of -20.0 pp.
TWST Competitors Peer median
Operating Margin for TWST and competitors
Company Period LTM level YoY 3-year change
RGENRepligen CorporationLTM Jun 20268.3% +11.9 pp-20.0 pp
TWSTTwist Bioscience CorporationLTM Sep 2026-30.4% +5.8 pp+58.2 pp
Peer median (excluding TWST) 8.3%+11.9 pp-20.0 pp

Competitors are the stored peer set for TWST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Revenue203.57M245.11M312.97M376.57M459.43M
Cost of Revenue119.33M155.38M179.63M185.57M218.63M
Gross Profit84.24M89.73M133.35M191M240.8M
Gross Margin41.4%36.6%42.6%50.7%52.4%
Research & Development120.31M106.89M90.85M80.29M71.84M
Selling, General & Admin212.95M189.74M218.4M246.98M301.22M
Operating Expenses319.01M306.89M354.18M327.26M380.26M
Depreciation & Amortization16.51M29.31M31.43M24.85M0
EBITDA(211.68M)(174.15M)(176.71M)(52.1M)(129.8M)
EBITDA Margin-104.0%-71.1%-56.5%-13.8%-28.3%
Operating Income(234.78M)(217.16M)(220.83M)(136.26M)(139.46M)
Operating Margin-115.3%-88.6%-70.6%-36.2%-30.4%
Interest Income3.06M14.37M15.34M11.36M8.8M
Interest Expense80K5K29K00
Other Income / Expenses6.5M13.69M12.67M59.31M8.85M
Income Before Tax(228.27M)(203.47M)(208.17M)(76.95M)(130.61M)
Pre-Tax Margin-112.1%-83.0%-66.5%-20.4%-28.4%
Income Tax Expense(10.41M)1.15M560K719K(406K)
Net Income(217.86M)(204.62M)(208.73M)(77.67M)(130.2M)
Net Margin-107.0%-83.5%-66.7%-20.6%-28.3%
EPS (Basic)(4.04)(3.60)(3.60)(1.30)(2.08)
EPS (Diluted)(4.04)(3.60)(3.60)(1.30)(2.08)
Weighted Avg Shares53.89M56.89M58.02M59.81M62.62M
Weighted Avg Shares (Diluted)53.89M56.89M58.02M59.81M62.62M

Twist Bioscience Corporation

NASDAQ:TWST

Intrinsic Alpha fair value

Locked

Current Price

$116.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.